More than an accessory: implications of type III transforming growth factor-β receptor loss in prostate cancer

被引：15

作者：

Ajiboye, Seun ^{[2
]}

Sissung, Tristan M.

Sharifi, Nima ^{[3
]}

Figg, William D. ^{[1
,2
]}

机构：

[1] NCI, Clin Pharmacol Program, Med Oncol Clin Res Unit, Med Oncol Branch,Ctr Canc Res, Bethesda, MD 20892 USA

[2] NCI, Mol Pharmacol Sect, Bethesda, MD 20892 USA

[3] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hematol & Oncol, Dallas, TX USA

来源：

BJU INTERNATIONAL | 2010年 / 105卷 / 07期

基金：

美国国家卫生研究院;

关键词：

betaglycan; TGF beta III receptor; prostate cancer; testosterone; TUMOR-SUPPRESSOR; CELL-MIGRATION; BETAGLYCAN; ACTIVINS; INHIBINS; ACTIVATION; EXPRESSION;

D O I：

10.1111/j.1464-410X.2009.08999.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The type III transforming growth factor-beta receptor (TGF beta R3, betaglycan), a tumour suppressor, is the most frequently lost TGF beta pathway component. This event appears to be very important in the transition of the TGF beta pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGF beta R3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGF beta R3 normally functions as an accessory protein in the TGF beta pathway, how its loss is related to tumour progression, and the treatment implications of TGF beta R3 loss in individuals with prostate cancer.

引用

页码：913 / 916

页数：4

共 50 条

[1] The type III transforming growth factor-β receptor as a novel tumor suppressor gene in prostate cancer
Turley, Ryan S.
Finger, Elizabeth C.
Hempel, Nadine
How, Tam
Fields, Timothy A.
Blobe, Gerard C.
[J]. CANCER RESEARCH, 2007, 67 (03) : 1090 - 1098
[2] A Role For The Accessory Type Iii Transforming Growth Factor-β Receptor In Post-Natal Lung Alveolarization
Pozarska, A. E.
Niess, G.
Seeger, W.
Morty, R. E.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[3] Transforming growth factor-β receptor III downregulation in prostate cancer:: is inhibin B a tumor suppressor in prostate?
Sharifi, Nima
Lechleider, Robert J.
Farrar, William L.
[J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2007, 39 (5-6) : 329 - 332
[4] Expression of transforming growth factor-β type I receptor and transforming growth factor-β type II receptor in rat retina
Shen, Wei
Liu, Lin
[J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2009, 2 (03) : 204 - 206
[5] Transforming growth factor-β1 and prostate cancer
Wikström, P
Bergh, A
Damber, JE
[J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 (02): : 85 - 94
[6] Expression of transforming growth factor-β type 1 receptor and transforming growth factor-β type 2 receptor in diabetic rat retina
Cao, Dan
Liu, Lin
Shen, Wei
[J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2008, 1 (04) : 297 - 300
[7] Knockdown of the transforming growth factor-β type III receptor impairs motility and invasion of metastatic cancer cells
Criswell, Tracy L.
Dumont, Nancy
Barnett, Joey V.
Arteaga, Carlos L.
[J]. CANCER RESEARCH, 2008, 68 (18) : 7304 - 7312
[8] Role of transforming growth factor-β1 in prostate cancer
Wikström, P
Damber, JE
Bergh, A
[J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2001, 52 (04) : 411 - 419
[9] Methylation silencing of transforming growth factor-β receptor type II in rat prostate cancers
Yamashita, Satoshi
Takahashi, Satoru
McDonell, Nathalie
Watanabe, Naoko
Niwa, Tohru
Hosoya, Kosuke
Tsujino, Yoshimi
Shirai, Tomoyuki
Ushijima, Toshikazu
[J]. CANCER RESEARCH, 2008, 68 (07) : 2112 - 2121
[10] Captopril restores transforming growth factor-β type II receptor and sensitivity to transforming growth factor-β in murine renal cell cancer cells
Miyajima, A
Asano, T
Hayakawa, M
[J]. JOURNAL OF UROLOGY, 2001, 165 (02): : 616 - 620

← 1 2 3 4 5 →